Navabshan Irfan

Navabshan Irfan

Active Director Director DIN 09341583
DIN 09341583 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Navabshan Irfan

Data last updated:

Navabshan Irfan is a Director at D3 Drug Tech Lab Private Limited (since 2021). The company operates in Chemicals.

DIN 09341583
Primary Designation Director
Industry Chemicals
First Appointment 30 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
D3 Drug Tech Lab Private Limited U24239TN2021PTC146678
Director30 Sep 20212021Active

Directorship timeline

Open interactive timeline →
D3 Drug Tech Lab Private Limited
Premium access

Shareholding and investment profile for Navabshan Irfan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Navabshan Irfan

Navabshan Irfan currently holds 1 directorship: D3 Drug Tech Lab Private Limited (Director, since 30 Sep 2021).

Navabshan Irfan was first appointed on 30 Sep 2021 as Director at D3 Drug Tech Lab Private Limited.

The current boards of Navabshan Irfan's companies include Murali Dhanya Varshini (D3 Drug Tech Lab Private Limited), Naleembukari Mohamedsaleem (D3 Drug Tech Lab Private Limited), Rizwan Navabjohn (D3 Drug Tech Lab Private Limited), Venkataraman Murali (D3 Drug Tech Lab Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available